Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Morepen Laboratories Ltd

NSE: MOREPENLAB · BSE: 500288 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹147.51
Market cap
₹8,083 Cr
Revenue (annual)
₹1,806 Cr
Net profit (annual)
₹94.88 Cr
P/E (TTM)
57.5×Sector 47.4×
Promoter holding
35.65%+0.00% QoQ
FII holding
1.46%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:53 IST NSE
Debt & Borrowing

Morepen Laboratories Debt & Borrowing: ₹30 Cr

Morepen Laboratories Limited has secured a ₹30 Crore unsecured term loan from Shinhan Bank. The facility carries an interest rate of 7.60% (Repo + 2.35% spread) with a 36-month tenure. The funds will be utilized for general business purposes, with repayment in 10 quarterly instalments after a 6-month moratorium.

Value
₹30.00 Cr
Execution
36 months
15:49 IST NSE
Debt & Borrowing

Morepen Laboratories Debt & Borrowing: ₹30 Cr

Morepen Laboratories Limited has secured a ₹30 Crore unsecured term loan from Shinhan Bank for general business purposes. The facility has a tenure of 36 months with a 6-month moratorium and is backed by a personal guarantee from the Chairman. This financing strengthens the company's liquidity position.

Value
₹30.00 Cr
Execution
36 months
14:20 IST BSE
Regulatory Approval

Morepen Laboratories Regulatory Approval

Morepen Laboratories successfully cleared a USFDA inspection at its Masulkhana, Himachal Pradesh API facility with zero observations (NIL Form 483). This marks the company's fourth consecutive successful inspection over eight years. The clearance reinforces Morepen's quality compliance for exporting APIs to regulated markets including the US and Europe.